[Thymus cancers: A clinical observation]

Area of Science:

• Oncology
• Thoracic Surgery

Background:

• Thymic tumors (thymomas, thymic carcinomas, carcinoid tumors) are rare, with an incidence of 0.13/100,000.
• These neoplasms exhibit diverse histologic and biologic features, ranging from indolent to aggressive behavior with metastasis.

Purpose of the Study:

• To review current literature on the epidemiology, classification, and therapeutic approaches for thymic tumors.
• To highlight the importance of the new TNM classification for treatment selection.

Main Methods:

• A comprehensive literature search was conducted to identify recent findings.
• The review focused on epidemiology, classification, and treatment modalities.

Main Results:

• Surgical resection is primary for Stage I-II thymomas; multimodal treatment is recommended for Stage III and pleural dissemination.
• Thymic tumors demonstrate chemosensitivity, while targeted therapies are reserved for palliative care post-chemotherapy failure.

Conclusions:

• The updated TNM (Tumor, Node, Metastasis) classification system is crucial for optimizing treatment strategies for thymic malignancies.
• Accurate staging is essential for guiding therapeutic decisions in patients with thymic tumors.